A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
Clinical trial NCT07145918 · RECRUITING
Trial details
- NCT number
- NCT07145918
- Sponsor
- AbbVie
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-04
- Primary completion
- 2028-02-01
- Enrollment
- 268
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.